March 31, 2023 at 11:19PM Vaccines and Related Biological Products Advisory Committee March 7, 2023 Meeting Announcement - 03/07/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee March 7, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6ueoHwf

March 31, 2023 at 10:08PM Coronavirus (COVID-19) | CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/87OVjts

March 31, 2023 at 03:53PM National Minority Health Month: Better Health Through Better Understanding

As the FDA observes National Minority Health Month this April, we are highlighting the Enhance Equity Initiative and our work to raise awareness on the importance of improving the health of racial and ethnic minority populations and reducing health disparities.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Xw4tkrA

Thursday, March 30, 2023

March 30, 2023 at 08:23PM Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development

The purpose of this guidance is to provide a framework for considering whether and what type of 59 long-term neurologic, sensory and developmental evaluations could be useful to support a 60 determination of safety of a drug, biological product, or device.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/isn8VGR

March 30, 2023 at 02:49PM Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions

Marketing Submission Recommendations for Predetermined Change Control Plans for AI/ML-Enabled Device Software Functions

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3y1wHWr

March 29, 2023 at 09:41PM FDA Patient Listening Sessions

Patient Listening Sessions led by FDA’s Office of Patient Affairs provide an opportunity for medical product Centers to engage with patients, caregivers, and advocates about their experiences and perspectives.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KlJEkqs

Wednesday, March 29, 2023

March 29, 2023 at 09:05PM Novavax COVID-19 Vaccine, Adjuvanted

Novavax COVID-19 Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BMxFz4o

March 29, 2023 at 08:40PM Guidance and Other Information of Special Interest to MCM Stakeholders

Information of particular interest to sponsors/applicants of medical countermeasures to treat, prevent, diagnose, and detect chemical, biological, radiological, and nuclear threats and emerging infectious diseases

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lhmkGeA

March 29, 2023 at 05:55PM Devices Guidances

This page lists Medical Device Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9hS0fw6

March 28, 2023 at 10:54PM Vaccines, Blood & Biologics

From blood to vaccines, FDA protects and advances the public health by ensuring that biological products are safe, effective, and available to those who need them. Read these Consumer Updates to learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rtiCJbM

Tuesday, March 28, 2023

March 28, 2023 at 08:54PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8tPIedb

Monday, March 27, 2023

March 27, 2023 at 04:27PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Rf2bBPW

Friday, March 24, 2023

March 24, 2023 at 07:58PM Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)

This policy allows certain modifications to the design and manufacturing of previously approved PMA and HDE devices during the COVID-19 pandemic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FhsGwaK

March 24, 2023 at 05:07PM Blood Products Advisory Committee April 26, 2023 Meeting Announcement - 04/26/2023

This is the main page for the Blood Products Advisory Committee April 26, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZGz2TU6

March 24, 2023 at 02:08PM FAQs: What happens to EUAs when a public health emergency ends?

Answers to frequently asked questions about what happens to Emergency Use Authorizations (EUAs), and medical products available under EUA, when a public health emergency ends.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/e3ncYUP

Thursday, March 23, 2023

March 23, 2023 at 09:06PM Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products - 04/27/2023

Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual public listening meeting to solicit input on methods and approaches (e.g., use of real-world evidence (RWE), registries) for capturing post approval safety and efficacy data for cell and gene therapy products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vRF2xgO

March 23, 2023 at 07:05PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6xN2zij

March 23, 2023 at 02:10PM Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products

This revised guidance document provides you, blood establishments that collect blood or blood components, including Source Plasma, with FDA’s revised donor deferral recommendations for individuals with increased risk for transmitting human immunodeficiency virus (HIV) infection.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bpjDtBU

Wednesday, March 22, 2023

March 22, 2023 at 08:07PM Development & Approval Process (CBER)

Key resources and information related to CBER development & approval process.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rbGqJ5O

March 22, 2023 at 06:36PM Moderna COVID-19 Vaccines

Information about Spikevax, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine, Bivalent. Updated COVID-19 vaccine boosters are now FDA-authorized.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zyasxq6

March 22, 2023 at 05:40PM Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Announcement - 02/28/2023

This is the main landing page for the Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mXd504N

March 22, 2023 at 02:12PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tQi8sHY

Tuesday, March 21, 2023

March 21, 2023 at 05:10PM Biological Product Deviation Reports Annual Summaries

Biological Product Deviation Reports Annual Summaries

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/URvalxf

Monday, March 20, 2023

March 20, 2023 at 01:25PM Cellular & Gene Therapy Products

CBER provides oversight of clinical studies, proactive scientific and regulatory advice to medical researchers and manufacturers of cellular therapy products, human gene therapy products, and certain devices related to cell and gene therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/DH7Wgcr

March 20, 2023 at 03:20PM Animal Rule Information

Links to information about the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/OGeI7XY

Friday, March 17, 2023

March 17, 2023 at 04:18PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XNc0Cxv

March 17, 2023 at 02:04PM FDA Patient Listening Sessions

Patient Listening Sessions led by FDA’s Office of Patient Affairs provide an opportunity for medical product Centers to engage with patients, caregivers, and advocates about their experiences and perspectives.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ujHYOPK

March 17, 2023 at 03:30PM Roster of the Allergenic Products Advisory Committee

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dg2IjYx

March 17, 2023 at 03:02PM Roster of the Blood Products Advisory Committee

This is the Roster of the Blood Products Advisory Committee (BPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/AfmyQ9F

Thursday, March 16, 2023

March 16, 2023 at 11:17AM Center for Biologics Evaluation and Research Patient Engagement Program

Patient input is a critical part of CBER’s understanding of diseases and conditions. Engaging with patients and listening to their perspectives on their diseases and treatments may help the center advance patient-focused medical product development.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/LdkYFfm

March 16, 2023 at 04:33PM Antihemophilic Factor (Recombinant)

Lists contain the Antihemophilic Factor (Recombinant) products with supporting documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/EZlMDqu

March 16, 2023 at 02:59PM New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) for CBER-Regulated Products

Historically, CBER has regulatory jurisdiction over some NDA products. Most NDAs are reviewed by the Center for Drug Evaluation and Research (CDER). There are only a few ANDAs currently regulated at CBER, e.g., ANDAs related to blood transfusion products. Most ANDAs are reviewed by CDER.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/fAHgSJO

Wednesday, March 15, 2023

March 15, 2023 at 09:04PM Clinical Guidances

This page lists Clinical Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RNeDkiK

March 15, 2023 at 05:18PM JYNNEOS

Indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/cGU58uI

Tuesday, March 14, 2023

March 14, 2023 at 07:48PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3CDSAEi

Monday, March 13, 2023

March 13, 2023 at 10:46PM Janssen COVID-19 Vaccine

Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/iofWrOR

March 13, 2023 at 10:24PM Investigational COVID-19 Convalescent Plasma

FDA plays a critical role in protecting the United States (U.S.) from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZpKtk2c

March 13, 2023 at 09:57PM Emergency Use Authorization for Vaccines to Prevent COVID-19

This is the Guidance for Industry for the Emergency Use Authorization for Vaccines to Prevent COVID-19. , COVID-19, Coronavirus Disease 2019, Vaccines , CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/w4PuU9C

March 13, 2023 at 07:45PM Vivotif

For immunization of adults and children greater than 6 years of age against disease caused by Salmonella typhi.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/L08hI4w

March 13, 2023 at 07:29PM VAXCHORA

VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/PRzrhyS

March 13, 2023 at 03:05PM Moderna COVID-19 Vaccines

Information about Spikevax, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine, Bivalent. Updated COVID-19 vaccine boosters are now FDA-authorized.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/arAsVJ4

Friday, March 10, 2023

March 10, 2023 at 07:51PM Cellular Therapy Products

Keith Wonnacott discusses information that is needed to prepare an investigational new drug application for a cellular therapy product.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/o0NtWR2

March 10, 2023 at 05:47PM Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research

The purpose of this guidance is to describe the recommendations of the Center for Biologics Evaluation and Research (CBER) on the use of standards in product development and control as well as the use of such standards in CBER’s managed review process. CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vAGXWIR

Thursday, March 9, 2023

March 09, 2023 at 08:40PM TENIVAC

TENIVAC is a product approval Indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4P68LNm

March 09, 2023 at 08:37PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/oNcRCwj

March 09, 2023 at 04:37PM Statistical Review and Evaluation - Fluarix

Statistical Review and Evaluation - Fluarix

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/B7auEnq

Wednesday, March 8, 2023

March 08, 2023 at 10:15PM SHINGRIX

This is the main page for the CBER SHINGRIX.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/YaKtiWj

March 08, 2023 at 07:02PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/aEf2SKk

March 08, 2023 at 06:17PM Measles, Mumps and Rubella Virus Vaccine Live

Product approval information for the Measles, Mumps, and Rubella Virus Vaccine, Live also known as M-M-R II.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XPsizd3

March 08, 2023 at 01:16PM Gamunex-C, Gammaked

For use in primary humoral immunodeficiency, idiopathic thrombocytopenic purpura and chronic inflammatory demyelinating polyneuropathy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rljGh9b

Tuesday, March 7, 2023

March 07, 2023 at 06:29PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BimpJkx

March 07, 2023 at 04:17PM PROQUAD

The Approval Letter and Approved Final Draft Labeling for Merck's Efficacy Supplement for Measles, Mumps, Rubella, and Varicella Vaccine, Live, (ProQuad®), to include concomitant administration with hepatitis A vaccine (VAQTA®) and/or pneumococcal conjugate vaccine (Prevnar®), use of ProQuad® in children 15 months to 12 years of age if a second dose of measles, mumps, rubella, and varicella is needed, additional safety data after a first or second dose of ProQuad®, and to comply with the Physician’s Labeling Rule format.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XCndZxb

March 07, 2023 at 02:39PM Cleared 510(k) Submissions with Supporting Documents

Listing of cleared 510(k) submissions with supporting documents. Information is reflected as of the clearance date.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/f9MiD3L

March 07, 2023 at 02:33PM Biological Approvals by Year

A collection of biological approval information organized by year and regulatory authorities.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zWRjK2k

March 07, 2023 at 02:19PM Recalls (Biologics)

Biologic recalls are listed by year. Recalls are a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/e5QoLrM

March 07, 2023 at 01:21PM Administrative Actions (Biologics)

This is the main page for the CBER Administrative Actions (Biologics).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8rFAVXb

Monday, March 6, 2023

March 06, 2023 at 08:24PM Biological Product Deviation Reports Annual Summaries

Biological Product Deviation Reports Annual Summaries

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gkYW01n

March 06, 2023 at 05:19PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XN8Hxyu

March 06, 2023 at 03:54PM COVID-19 Vaccines

FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tzOMwyP

March 06, 2023 at 12:54PM Workshops, Meetings & Conferences (Biologics)

Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NRvV457

Friday, March 3, 2023

March 03, 2023 at 11:55PM All Allergenic Extracts for Diagnosis of Food Allergy: FDA Safety Communication - FDA Requires Warning about Anaphylaxis Following False Negative Food Allergen Skin Test Results in the Prescribing Information 

FDA determined that the risk of anaphylaxis following false negative food allergen skin test results is applicable to all allergenic extracts for the diagnosis of food allergies. Requires Warning about Anaphylaxis Following False Negative Food Allergen Skin Test Results in Prescribing Information.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/68bEXY4

March 03, 2023 at 07:00PM FAQs: What happens to EUAs when a public health emergency ends?

Answers to frequently asked questions about what happens to Emergency Use Authorizations (EUAs), and medical products available under EUA, when a public health emergency ends.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ryJO48o

March 03, 2023 at 06:21PM Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Announcement - 02/28/2023

This is the main landing page for the Vaccines and Related Biological Products Advisory Committee February 28 - March 1, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FJiO0nT

March 03, 2023 at 03:07PM Clinical Trials: The Patient Experience - 04/13/2023

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a public virtual workshop on Thursday, April 13 from 11:00 a.m. – 3:00 p.m. ET.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/T4LRJED

March 03, 2023 at 01:38PM Vaccines and Related Biological Products Advisory Committee March 7, 2023 Meeting Announcement - 03/07/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee March 7, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZvNJLuV

Thursday, March 2, 2023

March 02, 2023 at 09:12PM Section 8000: General Information

This is the main page for CBER's SOPP Section 8000: General Information.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WzfqD4u

March 02, 2023 at 08:19PM Quadracel

Indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis. A single dose of Quadracel is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/390aeTX

March 02, 2023 at 07:29PM Prevnar 13

Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3YuWMxf

March 02, 2023 at 07:19PM Recently Issued Guidance Documents

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SKnwJ5D

March 02, 2023 at 03:31AM Fluarix Quadrivalent

For active immunization of persons 6 months and older for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NP7yjdc

March 02, 2023 at 02:24PM 2023 Meeting Materials, Blood Products Advisory Committee

This is the main page for the CBER 2023 Meeting Materials, Blood Products Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ryhVXkc

Wednesday, March 1, 2023

March 01, 2023 at 11:28PM VARIVAX (refrigerated and frozen formulations)

Product approval information for Varicella Virus Vaccine Live also known as Varivax.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2tplTuo

March 01, 2023 at 09:59PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gyPoz80

February 27, 2023 at 08:00PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hbIEpYw